The DOI matches its Crossref record; 276 of the 277 references it cites were found in a registry or an index; 180 of the 297 sources its claims cite were checked for support.
Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan
Open accessAbstract
The aged population, expected to double by 2050, makes up a large proportion of people living with metabolic disease. Obesity rates in the elderly are rapidly increasing, with estimates that nearly 40% of men and women over the age of 60 are classified as obese. White adipose tissue (WAT) is a highly metabolically active organ that undergoes significant changes during both obesity and aging, and metabolic dysfunction in WAT is a major cause for elevated diabetes risk. A marked difference in fat distribution is often reported between men and women. Many studies suggest that pre-menopausal women are protected from the accumulation of visceral adiposity due to gonadal estrogen, which exerts cardiometabolic benefits. Men with obesity harbor a disproportionately higher volume of intra-abdominal fat than premenopausal age-matched women with obesity, an effect that is negated by menopause as women begin to gain intra-abdominal fat. Post-menopausal women are at increased risk of developing diabetes, which can be mitigated by estrogen replacement therapy, suggesting an important role for sex steroids in diabetes risk. In addition to being highly responsive to gonadal estrogens, WAT has the capacity to convert androgens into estrogens, which may similarly impact WAT distribution and metabolism. Estrogens, comprised primarily of estrone (E1) and estradiol (E2) within WAT, are biosynthesized from circulating androgens androstenedione (A4) and testosterone (T) by aromatase (CYP19A1), which is highly expressed in human and mouse adipose tissue. In post-menopausal women, WAT becomes the predominant source of estrogen production, with age-associated increases in WAT aromatase expression that are mirrored by obesity. In contrast to ovarian estrogen production, in which E2 is the predominant estrogen type, E1 tends to be the predominant estrogen post-menopause. To date, little is known about WAT-derived estrogens and their impact on metabolic health, but emerging evidence suggests that increased E1 levels may contribute to metabolic dysfunction in aging. This review will introduce known sex differences in adipose metabolism associated with aging, obesity, and diabetes, and discuss the impact of WAT-derived sex hormones on local and systemic metabolism.
Overview
CoChat Summary
TL;DR
This narrative review argues that white adipose tissue (WAT) is an active site of estrogen biosynthesis via aromatase and that locally produced estrogens—especially the postmenopausal shift toward estrone—may influence fat distribution, inflammation, and insulin resistance in sex-, age-, and depot-dependent ways. It synthesizes human observational and rodent evidence but concludes that the direct metabolic roles of WAT-derived estrogens, particularly E1, remain incompletely understood.
Key findings
- WAT expresses aromatase (CYP19A1) and converts androgens to estrogens; after menopause WAT becomes the predominant estrogen source, with E1 rather than E2 dominating. In premenopausal women, WAT E1 concentrations were reported as 5–10 times higher in subcutaneous and visceral adipose tissue than serum, and aromatase expression correlated with VAT E1.
- Estrogen effects appear depot- and receptor-dependent: E2/ERα generally promotes subcutaneous lipid storage and insulin sensitivity, whereas E1 associates positively with BMI, waist circumference, and adiposity and, in postmenopausal women, inversely with adiponectin and insulin sensitivity. In obese mice, E1 produced a pro-inflammatory phenotype while E2 was anti-inflammatory.
- Metabolic risk shifts with menopause and aging: postmenopausal women face a five times greater risk of central obesity; an estimated 37.5% of men and 39.4% of women over age 60 in the United States are classified as obese; and T2D prevalence was estimated at 13% in men vs. 11% in women aged 20–79 in 2016.
- Menopausal hormone therapy findings are mixed: the Nurses’ Health Study (n=21,028) reported a 20% reduced diabetes risk in MHT users, and the PEPI trial showed improved fasting glucose and insulin, but benefits may depend on timing and delivery route. SHBG is inversely associated with insulin resistance/T2D, yet mouse overexpression studies conflict—no protection over 4.5 months of high-fat diet vs. protection over 8 weeks.
Methods
- Narrative review, not a systematic review or meta-analysis; it synthesizes human observational studies across the lifespan and preclinical rodent models.
- Covers adipocyte metabolism in healthy, aging, obese, and diabetic states; estrogen receptor biology; depot-specific aromatase activity and estrogen conversion; and menopausal hormone therapy.
- No primary data collection, systematic search strategy, or quantitative synthesis is described.
Limitations
- Stated in the paper: little is known about WAT-derived estrogens and their metabolic impact; the role of E1 in WAT function and energy metabolism remains much less understood; and whether E1 has direct metabolic effects or acts through local conversion to E2 is unclear.
- Stated in the paper: cross-sectional studies are limited in design; the SHBG–adiposity relationship is inconsistent, including a longitudinal finding that higher baseline SHBG may predict greater intra-abdominal adipose tissue gain, challenging cross-sectional results; MHT trials have mostly been in normal-weight women with modest reported effects; and no randomized controlled trials have directly examined metabolic impacts of oral vs. transdermal MHT.
- Evident from the text: as a narrative review, it reports no systematic search, inclusion criteria, risk-of-bias assessment, or quantitative synthesis, and conclusions rely on heterogeneous observational and rodent studies.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
120 Valid · 6 Not valid · 40 Not checked · 17 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“An in vivo experiment similarly showed that increased ERα expression increased skeletal muscle glucose uptake in ovariectomized female mice given E2 (151).”
§ Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan > Sex steroids and metabolic disease > Estradiol and estrone in metabolism
What the sources say
- Disputedcites [151] Gorres, 2011, In vivo stimulation of oestrogen receptor α increases insulin-stimulated skeletal muscle glucose uptake, J Physiol sourceExperimental — accuracy not yet measured
The Experimental animals and treatment section (page not available) identifies the animals as ovariectomized female rats, not mice, and describes separate estradiol benzoate (EB) and ERα-agonist (PPT) treatments. The Results section, “PPT increases insulin-stimulated glucose transport in soleus and EDL muscle” (page not available), says PPT increased uptake but EB did not; the study tested ERα activation, not increased ERα expression. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
Every source the paper cites for this claim was checked and supports it.
In the paper
“During reproductive years, when gonadal estradiol (E2) is the dominant estrogen, premenopausal women tend to accumulate more subcutaneous fat, particularly in the hips and thighs (10).”
§ Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan > Introduction
What the sources say
- Supportedcites [10] Steiner, 2022, The regulation of adipose tissue health by estrogens, Front Endocrinol (Lausanne) source
The section ‘The Regulation of Body Fat Distribution by Estrogens’ states that premenopausal females preferentially accumulate subcutaneous fat in the lower body, hips, and thighs. ‘Estrogen Action and Signaling Mechanisms’ identifies the ovaries as the main source of estrogen before menopause and 17β-estradiol as the major circulating form. Page numbers are not provided in our copy. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In terms of function and metabolism, older WAT exhibits reduced lipolysis and lipid storage capacity, driven by increased fibrosis and reduced plasticity (41).”
§ Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan > Adipocyte metabolism > Aging
What the sources say
- Partly supportedcites [41] Zhang, 2023, Adipose tissue aging is regulated by an altered immune system, Front Immunol sourceExperimental — accuracy not yet measured
The Background and Adipose tissue fibrosis sections report declining progenitor-cell function in aging WAT and increased WAT fibrosis in aged mice. The Ectopic lipid accumulation section describes impaired adipose-tissue buffering and lipid deposition elsewhere. The copy does not establish that older WAT has reduced lipolysis or that fibrosis and reduced plasticity drive both claimed functional losses; its mentions of lipolysis concern other mechanisms or interventions. The indexed passages provide section labels but no page numbers. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Aged WAT is characterized by a proinflammatory microenvironment with elevated expression of inflammatory genes associated with metabolic disease (39).”
§ Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan > Adipocyte metabolism > Aging
What the sources say
- Partly supportedcites [39] Lumeng, 2011, Inflammatory links between obesity and metabolic disease, J Clin Invest sourceExperimental — accuracy not yet measured
In “The nature of obesity-induced inflammation” (page unavailable), the paper reports overexpressed inflammatory genes in adipose tissue associated with obesity and metabolic disease. It also describes a shift toward proinflammatory macrophage signals with increasing adiposity. These passages support the inflammatory-gene and microenvironment aspects, but they concern obesity, not aged white adipose tissue; the aging qualifier is unsupported. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The WAT secretome is composed of cytokines, adipokines, and other factors, which can be reviewed here (12), and adipose depot location greatly influences metabolic health (13, 14).”
§ Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan > Adipocyte metabolism
What the sources say
- Supportedcites [13] Kahn, 2022, Exploring visceral and subcutaneous adipose tissue secretomes in human obesity: implications for metabolic disease, Endocrinology source
The Abstract states that adipose secretions vary by anatomical location and that visceral and subcutaneous depots differ in their effects on insulin responsiveness. The Discussion likewise describes a specifically negative role for visceral adipose tissue in hepatic metabolism. The copy does not provide page numbers for these passages. (LLM, conf=0.91)
- Supportedcites [14] Walker, 2014, The pathophysiology of abdominal adipose tissue depots in health and disease, Horm Mol Biol Clin Investig source
The Introduction (p. 1) says abdominal adipose tissue is a risk factor for metabolic disease, while gluteo-femoral adipose tissue has a protective role. The Adipose tissue depots section (p. 2) also links differences in metabolic risk at the same BMI to anatomical fat distribution. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
79 more claims · 56 with their cited sources checked
Create a free account to see all 183 claims and to verify the 3 references still open.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 84
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan > Sex steroids and metabolic disease
“-OVX improves HFD-induced insulin resistance in female mice (75).”
§ Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan > References
“Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan > Sex steroids and metabolic disease > Estradiol and estrone in metabolism
“Notably, metabolic tissues such as WAT, skeletal muscle, bone, and the heart have higher expression of ERα”
§ Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan > Sex steroids and metabolic disease > Estradiol and estrone in metabolism
“while other tissues such as bone, prostate, testes, and ovaries have higher expression of ERβ.”
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 1×
“…of fat from subcutaneous to visceral depots, particularly in post-menopausal women, which is associated with an increased risk for metabolic dysfunction, including insulin resistance (IR), as adipose tissue releases excess FFA and in fl ammatory mediators that impair insulin signaling (32, 33).”
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · cited 1×
“By contrast, excess vWAT is associated with metabolic syndrome, which includes the constellation of type 2 diabetes, hypertension, insulin resistance, dyslipidemia, systemic in fl ammation, and atherosclerosis (4, 5).”
Pathophysiology of human visceral obesity: an update
Tchernof, A., & Després, J.-P. (2013) · Physiological Reviews · doi:10.1152/physrev.00033.2011 · Cited by 2,583 · cited 1×
“…of fat from subcutaneous to visceral depots, particularly in post-menopausal women, which is associated with an increased risk for metabolic dysfunction, including insulin resistance (IR), as adipose tissue releases excess FFA and in fl ammatory mediators that impair insulin signaling (32, 33).”
Cinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S., Fortier, M., Greenberg, A. S., & Obin, M. S. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500294-jlr200 · Cited by 2,529
Dynamics of fat cell turnover in humans
Spalding, K. L., Arner, E., Westermark, P. O., Bernard, S., Buchholz, B. A., Bergmann, O., Blomqvist, L., Hoffstedt, J., Näslund, E., Britton, T., et al. (2008) · Nature · doi:10.1038/nature06902 · Cited by 2,357
Valery (1995) · doi:10.1001/jama.1995.03520270033028 · Cited by 2,320
Cited by
Pharmacotherapeutic considerations of selective estrogen receptor modulators for vascular protection
Banna, J. A., Karam, F., Hassanieh, D., Khanafer, Y., Ahmed, M. S., Sharara, H., & Eid, A. H. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1749904 · Cited by 3
“Such extra-gonadal activity becomes the predominant source of estrogen production in postmenopausal women and in men, highlighting its significance once ovarian and testicular output declines (Lee and Den Hartigh, 2025; Hetemaki et al., 2025).”
Akkour, K., Rafiullah, M., Alfadda, A. A., Alanazi, I. O., Masood, A., Joy, S. S., Al-Eidan, A. A., Alshehri, E., Bassi, A., Alhalal, H., et al. (2026) · Cells · doi:10.3390/cells15060498 · Cited by 2
“Patients with obesity are reported to have high adipose tissue-mediated estrogen production [9].”
WANG, M., Ding, H., Tong, T., & Han, L. (2026) · Applied Water Science · doi:10.1007/s13201-026-02907-w · Cited by 1
“Estrone (E1), the primary estrogen after menopause, can cause inflam - mation and metabolic dysfunction, thereby increasing the risk of breast cancer in women (Lee and Den Hartigh 2025; Qureshi et al. 2020 ).”
Biochemical pathways linking adiposity, diet, and endometrial carcinogenesis
Labudda, M., Sobieszek, K. A., Frankowski, J., et al. (2026) · Biochimie · doi:10.1016/j.biochi.2026.03.008 · Cited by 1
Dai, Y., Wang, Y., Huang, Y., Jiang, X. L., & Tan, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1731024 · Cited by 3
Metadata
- Authors
- Lee, A. A., & Den Hartigh, L. J.
- Affiliations
- University of Washington (US)
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2025-10-17
- Volume
- 16
- Pages
- 1682231-1682231
- ISSN
- 1664-2392 (ISSN-L)
- PMC
- PMC12575157
- OpenAlex
- W4415303743
- Semantic Scholar
- 9f6a4c438005dffa7c697a2cf384aba346de31fb
- Cited by
- 32
- References
- 274
- Citations by year
- 2026: 31 · 2025: 1
- FWCI
- 4.88
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Endocrinology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- white adipose tissue, aromatase, estrone, estradiol, menopause, sex differences, aging, obesity, visceral fat, intra-abdominal fat, diabetes risk, androgen to estrogen conversion, estrogen replacement therapy
- MeSH terms
- Adipose Tissue, Aging, Animals, Estrogens, Female, Humans, Longevity, Male, Obesity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan. https://app.cochat.ai/papers/10.3389/fendo.2025.1682231
- The paper
- Lee, A. A., & Den Hartigh, L. J. (2025). Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2025.1682231
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.